According to Montero, the myth implies that, after a god’s passing, its essence gets imprisoned in a mundane creature, subject to the cycles of life and death. Axolotl then carries within itself the ...

In the 1960s, a NASA-funded experiment aimed at fostering communication between humans and dolphins took a tragic turn.

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Margaret Howe Lovatt's experiment in the 1960s with a dolphin named Peter aimed to teach dolphins to speak English. Controversial interactions between Lovatt and Peter led to public outrage and ...

NASA likely didn't anticipate this ending after funding a study that saw a trainer and a dolphin get mighty close.

The Black Angels, boosted by their success against Florence, are preparing another salvation challenge. There is really no respite in this final phase ...

It isn't a cheap buy, but given its strong growth prospects, a premium is justifiable. Lilly could obtain approval for a weight loss pill that would unlock even more growth. Investors should never ...

Learn More » For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45 ...

Lilly Robertson, a senior at Ensworth High School, won the 50- and 100-yard freestyle state titles at the TISCA state championships. McCallie won the boys team title with 380 points, while Baylor ...

Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment for moderately to severely active Crohn's disease, extending its use beyond ulcerative colitis (UC) for the first time.

Eli Lilly has opened up a second market for its new Alzheimer's disease therapy Kisunla, after Japan followed the US in approving the drug. Kisunla (donanemab) is the second in a new generation of ...

Eli Lilly and Company (NYSE: LLY) will participate in TD Cowen's 45th Annual Health Care Conference on March 4, 2025. Jake Van Naarden, executive vice president and president, Lilly Oncology ...